International ID
From the Journals
Two-test sequence identifies sporadic Creutzfeldt-Jakob with 100% sensitivity, specificity
The sequential use of two diagnostic tests – one assessing cerebrospinal fluid and the other assessing nasal swabs – identifies sporadic...
From the Journals
Ebola research update: November 2016
Convalescent whole blood therapy is promising for treating Ebola virus disease in resource-poor settings, especially in the early phases of...
From the Journals
Ebola research update: October 2016
An unusual case of Ebola virus chain of transmission was uncovered in Conakry, Guinea, according to a recent study. Read about this and other...
From the Journals
Mefloquine labeling falls short on adverse reaction recommendations
Current safety guidance on the antimalarial drug mefloquine differs greatly across regions, according to an analysis of drug labeling and...
Conference Coverage
Lyme disease spirochete helps babesiosis gain a foothold
BOSTON – The spirochete that causes Lyme disease in humans may be helping to escalate the rate of human babesiosis cases in regions where both are...
From the Journals
Dengue vaccine beneficial only in moderate to high transmission settings
Seropositive pediatric patients benefit from dengue virus vaccination, but vaccination of seronegative patients leads to an increased risk for...
From the Journals
Health care workers at risk for mild MERS-CoV infections
Contracting MERS-CoV infection usually led to mild symptoms, making it harder to diagnose and treat, judging from findings from a new study.
From the Journals
ZMapp shows promise for Ebola treatment, but misses efficacy goal
ZMapp, a potential monoclonal antibody treatment for Ebola virus disease, did not meet its efficacy goal in a clinical trial of patients in...
From the Journals
Ebola research update: September 2016
Ebola virus disease complicated by multiple organ failure can be survivable with the application of advanced life support measures, a recent study...
Article
VIDEO: DNA-derived Zika vaccine in humans holds promise
BALTIMORE – Dr. Kathleen M. Neuzil, director of the University of Maryland’s Center for Vaccine Development, shares details on progress of the...
From the Journals
Levosimendan does not reduce organ dysfunction risk in sepsis
The calcium-sensitizing drug levosimendan does not reduce the likelihood of severe organ dysfunction in adults with sepsis or lower the mortality...